Translation-X
Basel
About Translation-X
Translation-X is a spin-off project that develops novel therapeutics for Autism spectrum disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $177.4K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2024)
- Website: trx-therapeutics.com
- Phone: +41 61 207 7153
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/translation-x-180575 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.